Position in PAHC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$250,320
-$14,172 QoQ
Shares Held
7,972
+66.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#125
of 206 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $16,343,377 across 32 Drug Manufacturers - Specialty & Generic names. PAHC ranks #25 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
40,027 | $2,097,414 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,432 | $1,859,560 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
10,634 | $1,792,254 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
134,034 | $1,340,340 | |
| 5 | LQDA |
Liquidia Corp
|
7,836 | $624,764 | |
| 6 | ZTS |
Zoetis Inc.
|
7,784 | $559,358 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,462 | $552,345 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
22,419 | $551,731 |
All Filings in PAHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,320 | 7,972 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $264,492 | 4,782 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $251,096 | 6,721 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||